Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Epam Systems Inc.

Start price
Target price
Perf. (%)
€355.60
01.11.22
€300.00
01.11.23
-41.45%
28.06.23

High Investments for future growth
Very valuable balance sheet
Leading role in innovation
Very positive Cash Flow expected
buy
Pharmaron Beijing Co. Ltd.

Start price
Target price
Perf. (%)
€3.80
01.11.22
-
01.11.23
40.79%
15.11.22

Could be worthwhile Investment >10% per year
buy
Longfor Group Holdings Limited

Start price
Target price
Perf. (%)
€1.35
01.11.22
-
01.11.23
88.15%
15.11.22

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€758.30
01.11.22
€900.00
01.11.23
-9.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€42.60
01.11.22
€55.00
31.12.24
-10.33%
04.11.22

Could be very worthwhile Investment >20% year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€88.01
01.11.22
€100.00
31.12.24
13.11%
05.05.23

Could be worthwhile Investment >10% per year
buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
01.11.22
€25.00
31.12.24
-0.27%
05.05.23

Could be worthwhile Investment >10% per year
buy
Inpixon

Start price
Target price
Perf. (%)
€3.18
31.10.22
-
31.10.23
6.00%
12.11.22

Could be worthwhile Investment >10% per year
Very capable Management
Little innovation
buy
Marathon Oil Corp.

Start price
Target price
Perf. (%)
€30.83
31.10.22
€45.00
31.12.23
-34.16%
05.05.23

Could be worthwhile Investment >10% per year
buy
Uber Technologies Inc

Start price
Target price
Perf. (%)
€27.51
31.10.22
€36.00
31.12.23
10.53%
01.11.22

Could be very worthwhile Investment >20% year
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€61.10
31.10.22
€48.00
31.12.24
0.98%
21.12.22

Could be worthwhile Investment >10% per year
Roku

Start price
Target price
Perf. (%)
€55.90
31.10.22
€43.00
31.12.24
-17.36%
03.11.22

Could be worthwhile Investment >10% per year
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€2.10
31.10.22
-
31.10.23
-3.81%
12.11.22

Could be worthwhile Investment >10% per year
Very capable Management
Few uniques
buy
Sonnet Biotherapeutics Holdings Inc.

Start price
Target price
Perf. (%)
€1.57
31.10.22
-
31.10.23
74.57%
01.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.47
31.10.22
€18.00
31.12.24
19.77%
31.10.22

Could be very worthwhile Investment >20% year
Bigbear.ai Holdings Inc.

Start price
Target price
Perf. (%)
€1.35
31.10.22
-
31.10.23
62.96%
24.04.23

Business model of the past or high risk
Risky Investment
buy
StoneCo Ltd

Start price
Target price
Perf. (%)
€10.31
30.10.22
€13.00
30.10.23
-11.85%
31.10.23

Could be worthwhile Investment >10% per year
buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.56
30.10.22
-
30.10.23
-16.12%
12.11.22

Risky Investment
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€2.10
30.10.22
-
30.10.23
-3.81%
12.11.22

Could be very worthwhile Investment >20% year
Dingdong (cayman) Ltd.

Start price
Target price
Perf. (%)
€2.54
30.10.22
-
30.10.23
38.58%
24.04.23

Probably not worthwhile Investment
GDS Holdings Ltd ADR

Start price
Target price
Perf. (%)
€8.40
30.10.22
-
30.10.23
61.90%
24.04.23

Probably not worthwhile Investment
China Mengniu Dairy Co Ltd

Start price
Target price
Perf. (%)
€3.15
30.10.22
-
30.10.23
11.64%
24.04.23

Probably not worthwhile Investment
buy
Oracle Corp.

Start price
Target price
Perf. (%)
€77.60
30.10.22
€80.00
30.10.23
2.81%
04.01.23

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.80
29.10.22
€400.00
29.10.23
6.95%
05.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
McDonalds Corp.

Start price
Target price
Perf. (%)
€273.00
29.10.22
€255.00
29.10.23
0.37%
22.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group